US2002111383A1PendingUtilityA1
Ultrafine L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
Assignee: SIGMA TAU HEALTHSCIENCE SPAPriority: Sep 3, 1999Filed: Feb 14, 2002Published: Aug 15, 2002
Est. expirySep 3, 2019(expired)· nominal 20-yr term from priority
Inventors:Ken Hassen
A61P 3/06A61P 9/00A61P 3/04A61P 3/00A61K 9/14A23L 33/175A61K 31/205A23V 2002/00
30
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
L-carnitine which has a particle size such that it substantially passes through a 100 USBS mesh sieve exhibits an increased bioavailability, a decreased hygroscopicity, and may be conveniently formulated with oil-based materials.
Claims
exact text as granted — not AI-modifiedWhat is claimed as new and desired to be secured by Letters Patent of the United States is:
1 . L-carnitine, having a particle size such that it substantially passes through a 100 USBS mesh sieve.
2 . The L-carnitine of claim 1 , which is selected from the group consisting of L-carnitine, salts of L-carnitine, alkanoyl L-carnitines, and salts of alkanoyl L-carnitine .
3 . The L-carnitine of claim 1 , which is selected from the group consisting of L-carnitine chloride, L-carnitine bromide, L-carnitine orotate, L-carnitine acid aspartate, L-carnitine acid phosphate, L-carnitine fumarate, L-carnitine lactate, L-carnitine maleate, L-carnitine acid maleate, L-carnitine acid oxalate, L-carnitine acid sulfate, L-carnitine glucose phosphate, L-carnitine tartrate, L-carnitine acid tartrate, L-carnitine iodate, L-carnitine aspartate, L-carnitine citrate, L-carnitine acid citrate, L-carnitine acid fumarate, L-carnitine glycerophosphate, L-carnitine mucate, L-carnitine orotate, L-carnitine oxalate, L-carnitine sulfate, L-carnitine trichloroacetate, L-carnitine trifluoroacetate, L-carnitine methanesulfonate, L-carnitine pamoate, L-carnitine acid pamoate, C 2-8 alkanoyl L-carnitines, C 2-8 alkanoyl L-carnitine chloride, C 2-8 alkanoyl L-carnitine bromide, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine acid aspartate, C 2-8 alkanoyl L-carnitine acid phosphate, C 2-8 alkanoyl L-carnitine fumarate, C 2-8 alkanoyl L-carnitine lactate, C 2-8 alkanoyl L-carnitine maleate, C 2-8 , alkanoyl L-carnitine acid maleate, C 2-8 alkanoyl L-carnitine acid oxalate, C 2-8 alkanoyl L-carnitine acid sulfate, C 2-8 alkanoyl L-carnitine glucose phosphate, C 2-8 alkanoyl L-carnitine tartrate, C 2-8 , alkanoyl L-carnitine acid tartrate, C 2-8 , alkanoyl L-carnitine iodate, C 2-8 alkanoyl L-carnitine aspartate, C 2-8 alkanoyl L-carnitine citrate, C 2-8 alkanoyl L-carnitine acid citrate, C 2-8 alkanoyl L-carnitine acid fimarate, C 2-8 alkanoyl L-carnitine glycerophosphate, C 2-8 alkanoyl L-carnitine mucate, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine oxalate, C 2-8 alkanoyl L-carnitine sulfate, C 2-8 alkanoyl L-carnitine trichloroacetate, C 2-8 alkanoyl L-carnitine trifluoroacetate, C 2-8 alkanoyl L-carnitine methanesulfonate, C 2-8 alkanoyl L-carnitine pamoate, and C 2-8 alkanoyl L-carnitine acid pamoate.
4 . A method of preparing L-carnitine, having a particle size such that it substantially passes through a 100 USBS mesh sieve, comprising:
(1) subjecting L-carnitine having a particle size such that it does not pass through a 100 USBS mesh sieve to size reduction, to obtain size-reduced L-carnitine; and (2) subjecting said size-reduced L-carnitine to sieving through a 100 USBS mesh sieve and selecting that portion which passes through said 100 USBS mesh sieve.
5 . The method of claim 4 , wherein said L-carnitine is selected from the group consisting of L-carnitine, salts of L-carnitine, alkanoyl L-carnitines, and salts of alkanoyl L-carnitine.
6 . The method of claim 4 , wherein said L-carnitine is selected from the group consisting of L-carnitine chloride, L-carnitine bromide, L-carnitine orotate, L-carnitine acid aspartate, L-carnitine acid phosphate, L-carnitine fumarate, L-carnitine lactate, L-carnitine maleate, L-carnitine acid maleate, L-carnitine acid oxalate, L-carnitine acid sulfate, L-carnitine glucose phosphate, L-carnitine tartrate, L-carnitine acid tartrate, L-carnitine iodate, L-carnitine aspartate, L-carnitine citrate, L-carnitine acid citrate, L-carnitine acid fumarate, L-carnitine glycerophosphate, L-carnitine mucate, L-carnitine orotate, L-carnitine oxalate, L-carnitine sulfate, L-carnitine trichloroacetate, L-carnitine trifluoroacetate, L-carnitine methanesulfonate, L-carnitine pamoate, L-carnitine acid pamoate, C 2-8 alkanoyl L-carnitines, C 2-8 alkanoyl L-carnitine chloride, C 2-8 alkanoyl L-carnitine bromide, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine acid aspartate, C 2-8 alkanoyl L-carnitine acid phosphate, C 2-8 alkanoyl L-carnitine fumarate, C 2-8 alkanoyl L-carnitine lactate, C 2-8 alkanoyl L-carnitine maleate, C 2-8 alkanoyl L-carnitine acid maleate, C 2-8 alkanoyl L-carnitine acid oxalate, C 2-8 alkanoyl L-carnitine acid sulfate, C 2-8 , alkanoyl L-carnitine glucose phosphate, C 2-8 alkanoyl L-carnitine tartrate, C 2-8 alkanoyl L-carnitine acid tartrate, C 2-8 alkanoyl L-carnitine iodate, C 2-8 alkanoyl L-carnitine aspartate, C 2-8 alkanoyl L-carnitine citrate, C 2-8 alkanoyl L-carnitine acid citrate, C 2-8 alkanoyl L-carnitine acid fumarate, C 2-8 alkanoyl L-carnitine glycerophosphate, C 2-8 alkanoyl L-carnitine mucate, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine oxalate, C 2-8 alkanoyl L-carnitine sulfate, C 2-8 alkanoyl L-carnitine trichloroacetate, C 2-8 alkanoyl L-carnitine trifluoroacetate, C 2-8 alkanoyl L-carnitine methanesulfonate, C 2-8 alkanoyl L-carnitine pamoate, and C 2-8 alkanoyl L-carnitine acid pamoate.
7 . A composition, comprising:
(A) L-carnitine having a particle size such that it substantially passes through a 100 USBS mesh sieve; and (B) a pharmaceutically acceptable excipient or carrier.
8 . The composition of claim 7 , wherein said L-carnitine is selected from the group consisting of L-carnitine, salts of L-carnitine, alkanoyl L-carnitines, and salts of alkanoyl L-carnitine.
9 . The composition of claim 7 , wherein said L-carnitine is selected from the group consisting of L-carnitine chloride, L-carnitine bromide, L-carnitine orotate, L-carnitine acid aspartate, L-carnitine acid phosphate, L-carnitine fumarate, L-carnitine lactate, L-carnitine maleate, L-carnitine acid maleate, L-carnitine acid oxalate, L-carnitine acid sulfate, L-carnitine glucose phosphate, L-carnitine tartrate, L-carnitine acid tartrate, L-carnitine iodate, L-carnitine aspartate, L-carnitine citrate, L-carnitine acid citrate, L-carnitine acid fumarate, L-carnitine glycerophosphate, L-carnitine mucate, L-carnitine orotate, L-carnitine oxalate, L-carnitine sulfate, L-carnitine trichloroacetate, L-carnitine trifluoroacetate, L-carnitine methanesulfonate, L-carnitine pamoate, L-carnitine acid pamoate, C 2-8 alkanoyl L-carnitines, C 2-8 alkanoyl L-carnitine chloride, C 2-8 alkanoyl L-carnitine bromide, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine acid aspartate, C 2-8 alkanoyl L-carnitine acid phosphate, C 2-8 alkanoyl L-carnitine fumarate, C 2-8 alkanoyl L-carnitine lactate, C 2-8 alkanoyl L-carnitine maleate, C 2-8 alkanoyl L-carnitine acid maleate, C 2-8 alkanoyl L-carnitine acid oxalate, C 2-8 alkanoyl L-carnitine acid sulfate, C 2-8 alkanoyl L-carnitine glucose phosphate, C 2-8 alkanoyl L-carnitine tartrate, C 2-8 alkanoyl L-carnitine acid tartrate, C 2-8 alkanoyl L-carnitine iodate, C 2-8 alkanoyl L-carnitine aspartate, C 2-8 alkanoyl L-carnitine citrate, C 2-8 alkanoyl L-carnitine acid citrate, C 2-8 alkanoyl L-carnitine acid fumarate, C 2-8 alkanoyl L-carnitine glycerophosphate, C 2-8 alkanoyl L-carnitine mucate, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine oxalate, C 2-8 alkanoyl L-carnitine sulfate, C 2-8 , alkanoyl L-carnitine trichloroacetate, C 2-8 alkanoyl L-carnitine trifluoroacetate, C 2-8 alkanoyl L-carnitine methanesulfonate, C 2-8 alkanoyl L-carnitine pamoate, and C 2-8 alkanoyl L-carnitine acid pamoate.
10 . The composition of claim 7 , which is suitable for oral ingestion.
11 . The composition of claim 7 , which further comprises hydroxycitric acid, Co-enzyme Q10, chromium picolinate, gamma linolenic acid, resveratrol, omega 3 acids, an antioxidant, or a vitamin.
12 . In a method of treatment, therapy, or prevention, comprising orally administering an effective amount of L-carnitine to a subject in need thereof, the improvement being said L-carnitine has a particle size such that it substantially passes through a 100 USBS mesh sieve.
13 . The method of claim 12 , wherein said L-carnitine is selected from the group consisting of L-carnitine, salts of L-carnitine, alkanoyl L-carnitines, and salts of alkanoyl L-carnitine.
14 . The method of claim 12 , wherein said L-carnitine is selected from the group consisting of L-carnitine chloride, L-carnitine bromide, L-carnitine orotate, L-carnitine acid aspartate, L-carnitine acid phosphate, L-carnitine fumarate, L-carnitine lactate, L-carnitine maleate, L-carnitine acid maleate, L-carnitine acid oxalate, L-carnitine acid sulfate, L-carnitine glucose phosphate, L-carnitine tartrate, L-carnitine acid tartrate, L-carnitine iodate, L-carnitine aspartate, L-carnitine citrate, L-carnitine acid citrate, L-carnitine acid fumarate, L-carnitine glycerophosphate, L-carnitine mucate, L-carnitine orotate, L-carnitine oxalate, L-carnitine sulfate, L-carnitine trichloroacetate, L-carnitine trifluoroacetate, L-carnitine methanesulfonate, L-carnitine pamoate, L-carnitine acid pamoate, C 2-8 alkanoyl L-carnitines, C 2-8 -alkanoyl L-carnitine chloride, C 2-8 alkanoyl L-carnitine bromide, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine acid aspartate, C 2-8 alkanoyl L-carnitine acid phosphate, C 2-8 alkanoyl L-carnitine fumarate, C 2-8 alkanoyl L-carnitine lactate, C 2-8 alkanoyl L-carnitine maleate, C 2-8 alkanoyl L-carnitine acid maleate, C 2-8 alkanoyl L-carnitine acid oxalate, C 2-8 alkanoyl L-carnitine acid sulfate, C 2-8 alkanoyl L-carnitine glucose phosphate, C 2-8 alkanoyl L-carnitine tartrate, C 2-8 alkanoyl L-carnitine acid tartrate, C 2-8 alkanoyl L-carnitine iodate, C 2-8 alkanoyl L-carnitine aspartate, C 2-8 alkanoyl L-carnitine citrate, C 2-8 , alkanoyl L-carnitine acid citrate, C 2-8 alkanoyl L-carnitine acid fumarate, C 2-8 alkanoyl L-carnitine glycerophosphate, C 2-8 alkanoyl L-carnitine mucate, C 2-8 alkanoyl L-carnitine orotate, C 2-8 alkanoyl L-carnitine oxalate, C 2-8 alkanoyl L-carnitine sulfate, C 2-8 alkanoyl L-carnitine trichloroacetate, C 2-8 alkanoyl L-carnitine trifluoroacetate, C 2-8 alkanoyl L-carnitine methanesulfonate, C 2-8 alkanoyl L-carnitine pamoate, and C 2-8 alkanoyl L-carnitine acid pamoate.Join the waitlist — get patent alerts
Track US2002111383A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.